AUTOLUS THERAPEUTICS PLC (AUTL) SEC News April 29, 2026, 21:28 UTC (70% Positive) AUTOLUS THERAPEUTICS PLC (AUTL) Provides Update on trial for lupus nephritis Full text
Register to leave comments News bot April 29, 2026, 9:29 p.m. 📋 AUTOLUS THERAPEUTICS PLC (AUTL) - Clinical Trial Update Filing Date: 2026-04-29 Accepted: 2026-04-29 17:28:25 Event Type: Clinical Trial Update Event Details: AUTOLUS THERAPEUTICS PLC (AUTL) Announces Clinical Trial Update AUTOLUS THERAPEUTICS PLC (AUTL) provided an update on its clinical development programs. Clinical Development Highlights: Drug Program: trial, reductionDiseases/Conditions: lupus nephritisClinical Stage: Phase 2 trial, Phase 2Collaboration: BOBCAT 💼 Business Developments: No business developments data available. Structured Data: Company Name: AUTOLUS THERAPEUTICS PLCTicker Symbol: AUTL
📋 AUTOLUS THERAPEUTICS PLC (AUTL) - Clinical Trial Update
Filing Date: 2026-04-29
Accepted: 2026-04-29 17:28:25
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
No business developments data available.
Structured Data: